February 6, 2019

Genetic ALS: Epidemiology and Testing

Virtual 2021 European Academy of Neurology (EAN) Annual Meeting

Welcome and Introduction

Dr. Ammar Al-Chalabi, from King’s College London, UK, discussed Genetic ALS: epidemiology and testing.

Key Learning Objectives from Biogen’s EAN 2021 Symposium:

  • Demonstrate the limitations of the familial / sporadic ALS classification system.
  • Gain insights into the epidemiology of genetic ALS.
  • Discuss the considerations for genetic testing in ALS patients.

Disclosure: All panelists received honoraria from Biogen for participation in this symposium.

Disclaimer: All of the information discussed today is for informational purposes only; does not constitute medical advice; and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment.